Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.

[1]  Melvin E Andersen,et al.  Co-culture of Hepatocytes and Kupffer Cells as an In Vitro Model of Inflammation and Drug-Induced Hepatotoxicity. , 2016, Journal of pharmaceutical sciences.

[2]  Aijuan Qu,et al.  Signal Transducer and Activator of Transcription 4 in Liver Diseases , 2015, International journal of biological sciences.

[3]  Mitchell R. McGill,et al.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. , 2014, Toxicology and applied pharmacology.

[4]  Zhuo Li,et al.  Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide. , 2014, World journal of gastrointestinal surgery.

[5]  H. Lijnen,et al.  Effect of Rosiglitazone on Liver Structure and Function in Genetically Diabetic Akita Mice , 2013, Basic & clinical pharmacology & toxicology.

[6]  A. Kamburov,et al.  Human Embryonic Stem Cell Derived Hepatocyte-Like Cells as a Tool for In Vitro Hazard Assessment of Chemical Carcinogenicity , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Yong-Mahn Han,et al.  Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro. , 2011, Human molecular genetics.

[8]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[9]  R. Birkhahn,et al.  Hepatic dysfunction and neurotoxicity in a patient receiving long-term low-dose amiodarone therapy. , 2010, The Journal of emergency medicine.

[10]  É. Vivier,et al.  Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response. , 2009, Cell host & microbe.

[11]  P. Lurie,et al.  Case series of liver failure associated with rosiglitazone and pioglitazone , 2009, Pharmacoepidemiology and drug safety.

[12]  M. Ingelman-Sundberg,et al.  Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  Ivan Rusyn,et al.  Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. , 2009, Genome research.

[14]  M. Ingelman-Sundberg,et al.  Pro-inflammatory response and adverse drug reactions: mechanisms of action of ximelagatran on chemokine and cytokine activation in a monocyte in vitro model. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  H. Moriwaki,et al.  Critical role of CD44 in hepatotoxin-mediated liver injury. , 2008, Journal of hepatology.

[16]  K. Jemnitz,et al.  Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  J. Itskovitz‐Eldor,et al.  Directed differentiation of human embryonic stem cells into functional hepatic cells , 2007, Hepatology.

[18]  H. Jaeschke.  Troglitazone hepatotoxicity: are we getting closer to understanding idiosyncratic liver injury? , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[20]  J. Senior,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[21]  H. Yoon,et al.  Transcriptional profiling of the developmentally important signalling pathways in human embryonic stem cells. , 2006, Human reproduction.

[22]  R. Kurten,et al.  Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: a kinetic study of proliferating cell nuclear antigen and cytokine expression. , 2005, Basic & clinical pharmacology & toxicology.

[23]  D. Laskin,et al.  Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. , 2003, Toxicology and applied pharmacology.

[24]  N. Kalia,et al.  Effects of aspirin and indomethacin on endothelial cell proliferation in vitro , 2003, Journal of gastroenterology and hepatology.

[25]  H. Haruyama,et al.  A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus , 2003, Clinical pharmacology and therapeutics.

[26]  L. Pohl,et al.  Protection against acetaminophen‐induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase , 2002, Hepatology.

[27]  A. Farhood,et al.  The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  R. Wilson,et al.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.

[29]  J. Talwalkar,et al.  Drug-induced liver injury. , 2014, Mayo Clinic proceedings.

[30]  J. Uetrecht,et al.  Immune-mediated adverse drug reactions. , 2009, Chemical research in toxicology.

[31]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[32]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[33]  S. R. Fine,et al.  ADVERSE DRUG REACTIONS , 2009, BMJ : British Medical Journal.